Eintrag weiter verarbeiten
Buchumschlag von Similarities and differences in the clinical features between cardia varices and esophageal varices
Verfügbar über Online-Ressource

Similarities and differences in the clinical features between cardia varices and esophageal varices

Gespeichert in:

Bibliographische Detailangaben
Zeitschriftentitel: Journal of Gastroenterology and Hepatology
Personen und Körperschaften: Kondo, Takayuki, Maruyama, Hitoshi, Kiyono, Soichiro, Sekimoto, Tadashi, Shimada, Taro, Takahashi, Masanori, Okugawa, Hidehiro, Kobayashi, Satoshi, Yoshizumi, Hiroaki, Yokosuka, Osamu
In: Journal of Gastroenterology and Hepatology, 29, 2014, 11, S. 1911-1918
Medientyp: E-Article
Sprache: Englisch
veröffentlicht:
Wiley
Schlagwörter:
author_facet Kondo, Takayuki
Maruyama, Hitoshi
Kiyono, Soichiro
Sekimoto, Tadashi
Shimada, Taro
Takahashi, Masanori
Okugawa, Hidehiro
Kobayashi, Satoshi
Yoshizumi, Hiroaki
Yokosuka, Osamu
Kondo, Takayuki
Maruyama, Hitoshi
Kiyono, Soichiro
Sekimoto, Tadashi
Shimada, Taro
Takahashi, Masanori
Okugawa, Hidehiro
Kobayashi, Satoshi
Yoshizumi, Hiroaki
Yokosuka, Osamu
author Kondo, Takayuki
Maruyama, Hitoshi
Kiyono, Soichiro
Sekimoto, Tadashi
Shimada, Taro
Takahashi, Masanori
Okugawa, Hidehiro
Kobayashi, Satoshi
Yoshizumi, Hiroaki
Yokosuka, Osamu
spellingShingle Kondo, Takayuki
Maruyama, Hitoshi
Kiyono, Soichiro
Sekimoto, Tadashi
Shimada, Taro
Takahashi, Masanori
Okugawa, Hidehiro
Kobayashi, Satoshi
Yoshizumi, Hiroaki
Yokosuka, Osamu
Journal of Gastroenterology and Hepatology
Similarities and differences in the clinical features between cardia varices and esophageal varices
Gastroenterology
Hepatology
author_sort kondo, takayuki
spelling Kondo, Takayuki Maruyama, Hitoshi Kiyono, Soichiro Sekimoto, Tadashi Shimada, Taro Takahashi, Masanori Okugawa, Hidehiro Kobayashi, Satoshi Yoshizumi, Hiroaki Yokosuka, Osamu 0815-9319 1440-1746 Wiley Gastroenterology Hepatology http://dx.doi.org/10.1111/jgh.12647 <jats:title>Abstract</jats:title><jats:sec><jats:title>Background and Aim</jats:title><jats:p>Little is known about the clinical features of cardia varices (<jats:styled-content style="fixed-case">CV</jats:styled-content>). The aim was to examine the background, bleeding risk, and post‐treatment outcomes of <jats:styled-content style="fixed-case">CV</jats:styled-content> in patients with portal hypertension.</jats:p></jats:sec><jats:sec><jats:title>Methods</jats:title><jats:p>The subjects of this retrospective study were 277 patients (179 males, 98 females, 62.9 ± 11.5 years) with esophageal varices (<jats:styled-content style="fixed-case">EV</jats:styled-content>). In patients with CV, there were 65 bleeders, and 95 patients received endoscopic treatment for primary or secondary prophylaxis.</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>There were 147 patients with <jats:styled-content style="fixed-case">CV</jats:styled-content> (53.1%). The higher grade of <jats:styled-content style="fixed-case">EV</jats:styled-content> (<jats:italic>P</jats:italic> &lt; 0.01) and the lower grade of gastric fundal varices (<jats:styled-content style="fixed-case">FV</jats:styled-content>) (<jats:italic>P</jats:italic> = 0.046) were significant factors for the presence of <jats:styled-content style="fixed-case">CV</jats:styled-content>. Significant risk factors for bleeding were: the higher grade of <jats:styled-content style="fixed-case">EV</jats:styled-content> (<jats:italic>P</jats:italic> &lt; 0.01), red sign on <jats:styled-content style="fixed-case">EV</jats:styled-content> (<jats:italic>P</jats:italic> &lt; 0.01), lower albumin (<jats:italic>P</jats:italic> = 0.01), and <jats:styled-content style="fixed-case">C</jats:styled-content>hild‐<jats:styled-content style="fixed-case">P</jats:styled-content>ugh B/C (<jats:italic>P</jats:italic> &lt; 0.01) for <jats:styled-content style="fixed-case">EV</jats:styled-content> and red sign on <jats:styled-content style="fixed-case">CV</jats:styled-content> (<jats:italic>P</jats:italic> &lt; 0.01) and use of non‐steroidal anti‐inflammatory drugs (<jats:styled-content style="fixed-case">NSAID</jats:styled-content>s)/aspirin (<jats:italic>P</jats:italic> &lt; 0.01) for <jats:styled-content style="fixed-case">CV</jats:styled-content>. All <jats:styled-content style="fixed-case">CV</jats:styled-content> disappeared by sclerotherapy combined with argon plasma coagulation or band ligation, and 20 patients (21.1%) in EV and 18 patients (18.9%) in CV had recurrences during the median observation period of 19.4 months. There was no significant difference in the cumulative survival rate between non‐bleeders, bleeders from <jats:styled-content style="fixed-case">EV</jats:styled-content>, and those from <jats:styled-content style="fixed-case">CV</jats:styled-content>.</jats:p></jats:sec><jats:sec><jats:title>Conclusions</jats:title><jats:p>The <jats:styled-content style="fixed-case">CV</jats:styled-content> were closely associated with advanced grade of <jats:styled-content style="fixed-case">EV</jats:styled-content> and less‐advanced grade of <jats:styled-content style="fixed-case">FV</jats:styled-content>. Further, usage of <jats:styled-content style="fixed-case">NSAIDs</jats:styled-content>/aspirin and red sign were significantly related to the bleeding from <jats:styled-content style="fixed-case">CV</jats:styled-content>, suggesting the need for careful management.</jats:p></jats:sec> Similarities and differences in the clinical features between cardia varices and esophageal varices Journal of Gastroenterology and Hepatology
doi_str_mv 10.1111/jgh.12647
facet_avail Online
finc_class_facet Medizin
format ElectronicArticle
fullrecord blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTExMS9qZ2guMTI2NDc
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTExMS9qZ2guMTI2NDc
institution DE-Pl11
DE-Rs1
DE-105
DE-14
DE-Ch1
DE-L229
DE-D275
DE-Bn3
DE-Brt1
DE-D161
DE-Gla1
DE-Zi4
DE-15
imprint Wiley, 2014
imprint_str_mv Wiley, 2014
issn 0815-9319
1440-1746
issn_str_mv 0815-9319
1440-1746
language English
mega_collection Wiley (CrossRef)
match_str kondo2014similaritiesanddifferencesintheclinicalfeaturesbetweencardiavaricesandesophagealvarices
publishDateSort 2014
publisher Wiley
recordtype ai
record_format ai
series Journal of Gastroenterology and Hepatology
source_id 49
title Similarities and differences in the clinical features between cardia varices and esophageal varices
title_unstemmed Similarities and differences in the clinical features between cardia varices and esophageal varices
title_full Similarities and differences in the clinical features between cardia varices and esophageal varices
title_fullStr Similarities and differences in the clinical features between cardia varices and esophageal varices
title_full_unstemmed Similarities and differences in the clinical features between cardia varices and esophageal varices
title_short Similarities and differences in the clinical features between cardia varices and esophageal varices
title_sort similarities and differences in the clinical features between cardia varices and esophageal varices
topic Gastroenterology
Hepatology
url http://dx.doi.org/10.1111/jgh.12647
publishDate 2014
physical 1911-1918
description <jats:title>Abstract</jats:title><jats:sec><jats:title>Background and Aim</jats:title><jats:p>Little is known about the clinical features of cardia varices (<jats:styled-content style="fixed-case">CV</jats:styled-content>). The aim was to examine the background, bleeding risk, and post‐treatment outcomes of <jats:styled-content style="fixed-case">CV</jats:styled-content> in patients with portal hypertension.</jats:p></jats:sec><jats:sec><jats:title>Methods</jats:title><jats:p>The subjects of this retrospective study were 277 patients (179 males, 98 females, 62.9 ± 11.5 years) with esophageal varices (<jats:styled-content style="fixed-case">EV</jats:styled-content>). In patients with CV, there were 65 bleeders, and 95 patients received endoscopic treatment for primary or secondary prophylaxis.</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>There were 147 patients with <jats:styled-content style="fixed-case">CV</jats:styled-content> (53.1%). The higher grade of <jats:styled-content style="fixed-case">EV</jats:styled-content> (<jats:italic>P</jats:italic> &lt; 0.01) and the lower grade of gastric fundal varices (<jats:styled-content style="fixed-case">FV</jats:styled-content>) (<jats:italic>P</jats:italic> = 0.046) were significant factors for the presence of <jats:styled-content style="fixed-case">CV</jats:styled-content>. Significant risk factors for bleeding were: the higher grade of <jats:styled-content style="fixed-case">EV</jats:styled-content> (<jats:italic>P</jats:italic> &lt; 0.01), red sign on <jats:styled-content style="fixed-case">EV</jats:styled-content> (<jats:italic>P</jats:italic> &lt; 0.01), lower albumin (<jats:italic>P</jats:italic> = 0.01), and <jats:styled-content style="fixed-case">C</jats:styled-content>hild‐<jats:styled-content style="fixed-case">P</jats:styled-content>ugh B/C (<jats:italic>P</jats:italic> &lt; 0.01) for <jats:styled-content style="fixed-case">EV</jats:styled-content> and red sign on <jats:styled-content style="fixed-case">CV</jats:styled-content> (<jats:italic>P</jats:italic> &lt; 0.01) and use of non‐steroidal anti‐inflammatory drugs (<jats:styled-content style="fixed-case">NSAID</jats:styled-content>s)/aspirin (<jats:italic>P</jats:italic> &lt; 0.01) for <jats:styled-content style="fixed-case">CV</jats:styled-content>. All <jats:styled-content style="fixed-case">CV</jats:styled-content> disappeared by sclerotherapy combined with argon plasma coagulation or band ligation, and 20 patients (21.1%) in EV and 18 patients (18.9%) in CV had recurrences during the median observation period of 19.4 months. There was no significant difference in the cumulative survival rate between non‐bleeders, bleeders from <jats:styled-content style="fixed-case">EV</jats:styled-content>, and those from <jats:styled-content style="fixed-case">CV</jats:styled-content>.</jats:p></jats:sec><jats:sec><jats:title>Conclusions</jats:title><jats:p>The <jats:styled-content style="fixed-case">CV</jats:styled-content> were closely associated with advanced grade of <jats:styled-content style="fixed-case">EV</jats:styled-content> and less‐advanced grade of <jats:styled-content style="fixed-case">FV</jats:styled-content>. Further, usage of <jats:styled-content style="fixed-case">NSAIDs</jats:styled-content>/aspirin and red sign were significantly related to the bleeding from <jats:styled-content style="fixed-case">CV</jats:styled-content>, suggesting the need for careful management.</jats:p></jats:sec>
container_issue 11
container_start_page 1911
container_title Journal of Gastroenterology and Hepatology
container_volume 29
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
_version_ 1792334811233255434
geogr_code not assigned
last_indexed 2024-03-01T14:34:35.425Z
geogr_code_person not assigned
openURL url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Similarities+and+differences+in+the+clinical+features+between+cardia+varices+and+esophageal+varices&rft.date=2014-11-01&genre=article&issn=1440-1746&volume=29&issue=11&spage=1911&epage=1918&pages=1911-1918&jtitle=Journal+of+Gastroenterology+and+Hepatology&atitle=Similarities+and+differences+in+the+clinical+features+between+cardia+varices+and+esophageal+varices&aulast=Yokosuka&aufirst=Osamu&rft_id=info%3Adoi%2F10.1111%2Fjgh.12647&rft.language%5B0%5D=eng
SOLR
_version_ 1792334811233255434
author Kondo, Takayuki, Maruyama, Hitoshi, Kiyono, Soichiro, Sekimoto, Tadashi, Shimada, Taro, Takahashi, Masanori, Okugawa, Hidehiro, Kobayashi, Satoshi, Yoshizumi, Hiroaki, Yokosuka, Osamu
author_facet Kondo, Takayuki, Maruyama, Hitoshi, Kiyono, Soichiro, Sekimoto, Tadashi, Shimada, Taro, Takahashi, Masanori, Okugawa, Hidehiro, Kobayashi, Satoshi, Yoshizumi, Hiroaki, Yokosuka, Osamu, Kondo, Takayuki, Maruyama, Hitoshi, Kiyono, Soichiro, Sekimoto, Tadashi, Shimada, Taro, Takahashi, Masanori, Okugawa, Hidehiro, Kobayashi, Satoshi, Yoshizumi, Hiroaki, Yokosuka, Osamu
author_sort kondo, takayuki
container_issue 11
container_start_page 1911
container_title Journal of Gastroenterology and Hepatology
container_volume 29
description <jats:title>Abstract</jats:title><jats:sec><jats:title>Background and Aim</jats:title><jats:p>Little is known about the clinical features of cardia varices (<jats:styled-content style="fixed-case">CV</jats:styled-content>). The aim was to examine the background, bleeding risk, and post‐treatment outcomes of <jats:styled-content style="fixed-case">CV</jats:styled-content> in patients with portal hypertension.</jats:p></jats:sec><jats:sec><jats:title>Methods</jats:title><jats:p>The subjects of this retrospective study were 277 patients (179 males, 98 females, 62.9 ± 11.5 years) with esophageal varices (<jats:styled-content style="fixed-case">EV</jats:styled-content>). In patients with CV, there were 65 bleeders, and 95 patients received endoscopic treatment for primary or secondary prophylaxis.</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>There were 147 patients with <jats:styled-content style="fixed-case">CV</jats:styled-content> (53.1%). The higher grade of <jats:styled-content style="fixed-case">EV</jats:styled-content> (<jats:italic>P</jats:italic> &lt; 0.01) and the lower grade of gastric fundal varices (<jats:styled-content style="fixed-case">FV</jats:styled-content>) (<jats:italic>P</jats:italic> = 0.046) were significant factors for the presence of <jats:styled-content style="fixed-case">CV</jats:styled-content>. Significant risk factors for bleeding were: the higher grade of <jats:styled-content style="fixed-case">EV</jats:styled-content> (<jats:italic>P</jats:italic> &lt; 0.01), red sign on <jats:styled-content style="fixed-case">EV</jats:styled-content> (<jats:italic>P</jats:italic> &lt; 0.01), lower albumin (<jats:italic>P</jats:italic> = 0.01), and <jats:styled-content style="fixed-case">C</jats:styled-content>hild‐<jats:styled-content style="fixed-case">P</jats:styled-content>ugh B/C (<jats:italic>P</jats:italic> &lt; 0.01) for <jats:styled-content style="fixed-case">EV</jats:styled-content> and red sign on <jats:styled-content style="fixed-case">CV</jats:styled-content> (<jats:italic>P</jats:italic> &lt; 0.01) and use of non‐steroidal anti‐inflammatory drugs (<jats:styled-content style="fixed-case">NSAID</jats:styled-content>s)/aspirin (<jats:italic>P</jats:italic> &lt; 0.01) for <jats:styled-content style="fixed-case">CV</jats:styled-content>. All <jats:styled-content style="fixed-case">CV</jats:styled-content> disappeared by sclerotherapy combined with argon plasma coagulation or band ligation, and 20 patients (21.1%) in EV and 18 patients (18.9%) in CV had recurrences during the median observation period of 19.4 months. There was no significant difference in the cumulative survival rate between non‐bleeders, bleeders from <jats:styled-content style="fixed-case">EV</jats:styled-content>, and those from <jats:styled-content style="fixed-case">CV</jats:styled-content>.</jats:p></jats:sec><jats:sec><jats:title>Conclusions</jats:title><jats:p>The <jats:styled-content style="fixed-case">CV</jats:styled-content> were closely associated with advanced grade of <jats:styled-content style="fixed-case">EV</jats:styled-content> and less‐advanced grade of <jats:styled-content style="fixed-case">FV</jats:styled-content>. Further, usage of <jats:styled-content style="fixed-case">NSAIDs</jats:styled-content>/aspirin and red sign were significantly related to the bleeding from <jats:styled-content style="fixed-case">CV</jats:styled-content>, suggesting the need for careful management.</jats:p></jats:sec>
doi_str_mv 10.1111/jgh.12647
facet_avail Online
finc_class_facet Medizin
format ElectronicArticle
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
geogr_code not assigned
geogr_code_person not assigned
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTExMS9qZ2guMTI2NDc
imprint Wiley, 2014
imprint_str_mv Wiley, 2014
institution DE-Pl11, DE-Rs1, DE-105, DE-14, DE-Ch1, DE-L229, DE-D275, DE-Bn3, DE-Brt1, DE-D161, DE-Gla1, DE-Zi4, DE-15
issn 0815-9319, 1440-1746
issn_str_mv 0815-9319, 1440-1746
language English
last_indexed 2024-03-01T14:34:35.425Z
match_str kondo2014similaritiesanddifferencesintheclinicalfeaturesbetweencardiavaricesandesophagealvarices
mega_collection Wiley (CrossRef)
physical 1911-1918
publishDate 2014
publishDateSort 2014
publisher Wiley
record_format ai
recordtype ai
series Journal of Gastroenterology and Hepatology
source_id 49
spelling Kondo, Takayuki Maruyama, Hitoshi Kiyono, Soichiro Sekimoto, Tadashi Shimada, Taro Takahashi, Masanori Okugawa, Hidehiro Kobayashi, Satoshi Yoshizumi, Hiroaki Yokosuka, Osamu 0815-9319 1440-1746 Wiley Gastroenterology Hepatology http://dx.doi.org/10.1111/jgh.12647 <jats:title>Abstract</jats:title><jats:sec><jats:title>Background and Aim</jats:title><jats:p>Little is known about the clinical features of cardia varices (<jats:styled-content style="fixed-case">CV</jats:styled-content>). The aim was to examine the background, bleeding risk, and post‐treatment outcomes of <jats:styled-content style="fixed-case">CV</jats:styled-content> in patients with portal hypertension.</jats:p></jats:sec><jats:sec><jats:title>Methods</jats:title><jats:p>The subjects of this retrospective study were 277 patients (179 males, 98 females, 62.9 ± 11.5 years) with esophageal varices (<jats:styled-content style="fixed-case">EV</jats:styled-content>). In patients with CV, there were 65 bleeders, and 95 patients received endoscopic treatment for primary or secondary prophylaxis.</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>There were 147 patients with <jats:styled-content style="fixed-case">CV</jats:styled-content> (53.1%). The higher grade of <jats:styled-content style="fixed-case">EV</jats:styled-content> (<jats:italic>P</jats:italic> &lt; 0.01) and the lower grade of gastric fundal varices (<jats:styled-content style="fixed-case">FV</jats:styled-content>) (<jats:italic>P</jats:italic> = 0.046) were significant factors for the presence of <jats:styled-content style="fixed-case">CV</jats:styled-content>. Significant risk factors for bleeding were: the higher grade of <jats:styled-content style="fixed-case">EV</jats:styled-content> (<jats:italic>P</jats:italic> &lt; 0.01), red sign on <jats:styled-content style="fixed-case">EV</jats:styled-content> (<jats:italic>P</jats:italic> &lt; 0.01), lower albumin (<jats:italic>P</jats:italic> = 0.01), and <jats:styled-content style="fixed-case">C</jats:styled-content>hild‐<jats:styled-content style="fixed-case">P</jats:styled-content>ugh B/C (<jats:italic>P</jats:italic> &lt; 0.01) for <jats:styled-content style="fixed-case">EV</jats:styled-content> and red sign on <jats:styled-content style="fixed-case">CV</jats:styled-content> (<jats:italic>P</jats:italic> &lt; 0.01) and use of non‐steroidal anti‐inflammatory drugs (<jats:styled-content style="fixed-case">NSAID</jats:styled-content>s)/aspirin (<jats:italic>P</jats:italic> &lt; 0.01) for <jats:styled-content style="fixed-case">CV</jats:styled-content>. All <jats:styled-content style="fixed-case">CV</jats:styled-content> disappeared by sclerotherapy combined with argon plasma coagulation or band ligation, and 20 patients (21.1%) in EV and 18 patients (18.9%) in CV had recurrences during the median observation period of 19.4 months. There was no significant difference in the cumulative survival rate between non‐bleeders, bleeders from <jats:styled-content style="fixed-case">EV</jats:styled-content>, and those from <jats:styled-content style="fixed-case">CV</jats:styled-content>.</jats:p></jats:sec><jats:sec><jats:title>Conclusions</jats:title><jats:p>The <jats:styled-content style="fixed-case">CV</jats:styled-content> were closely associated with advanced grade of <jats:styled-content style="fixed-case">EV</jats:styled-content> and less‐advanced grade of <jats:styled-content style="fixed-case">FV</jats:styled-content>. Further, usage of <jats:styled-content style="fixed-case">NSAIDs</jats:styled-content>/aspirin and red sign were significantly related to the bleeding from <jats:styled-content style="fixed-case">CV</jats:styled-content>, suggesting the need for careful management.</jats:p></jats:sec> Similarities and differences in the clinical features between cardia varices and esophageal varices Journal of Gastroenterology and Hepatology
spellingShingle Kondo, Takayuki, Maruyama, Hitoshi, Kiyono, Soichiro, Sekimoto, Tadashi, Shimada, Taro, Takahashi, Masanori, Okugawa, Hidehiro, Kobayashi, Satoshi, Yoshizumi, Hiroaki, Yokosuka, Osamu, Journal of Gastroenterology and Hepatology, Similarities and differences in the clinical features between cardia varices and esophageal varices, Gastroenterology, Hepatology
title Similarities and differences in the clinical features between cardia varices and esophageal varices
title_full Similarities and differences in the clinical features between cardia varices and esophageal varices
title_fullStr Similarities and differences in the clinical features between cardia varices and esophageal varices
title_full_unstemmed Similarities and differences in the clinical features between cardia varices and esophageal varices
title_short Similarities and differences in the clinical features between cardia varices and esophageal varices
title_sort similarities and differences in the clinical features between cardia varices and esophageal varices
title_unstemmed Similarities and differences in the clinical features between cardia varices and esophageal varices
topic Gastroenterology, Hepatology
url http://dx.doi.org/10.1111/jgh.12647